|
|
||||||||
1 Divisions of Clinical Virology, F68, and Oral Microbiology, F88, Huddinge University Hospital, S-141 86 Huddinge, Sweden
2 Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, USA
3 Department of Biochemistry and Molecular Biophysics, Virginia Commonwealth University, Richmond, Virginia, USA
4 Immune Complex Corporation, San Diego, California, USA
The immunogenicity and antigenicity of an enzymatically functional (ATPase/helicase) recombinant protein encompassing residues 12071612 of the hepatitis C virus (HCV) non-structural 3 (NS3) protein was characterized using B10 congenic mice. Previous studies have indicated a high frequency of NS3-specific antibodies in HCV-infected humans. Similarly, all six immunized murine haplotypes were antibody responders to the NS3 ATPase/helicase domain, with the H-2k and H-2s haplotypes as high responders. As also observed in HCV-infected humans, the murine NS3 antibodies were predominantly directed to conformational determinants. Irrespective of the murine haplotype, IgG1 predominated in the primary anti-NS3 response, whereas IgG1 and IgG2b predominated in the secondary response. The antibody responder hierarchy was reiterated at the T cell level, with the H-2k and the H-2s haplotypes as the best responders. In both the H-2d and H-2k haplotypes ATPase/helicase-primed T cells secreted interleukin 2 and interferon
, corroborating observations from HCV-infected humans. In the H-2d, H-2k and H-2s haplotypes the fine specificity of the T cell recognition of the ATPase/helicase domain was further characterized. Multiple, although generally weak, T cell recognition sites were found for all three haplotypes. The large size of the NS3 protein together with the presence of multiple class II binding motifs explain the high prevalence of NS3 antibodies in immunized mice and predict a similar explanation for the observed high frequency of NS3-specific antibodies in HCV-infected humans.
Received 23 April 1996;
accepted 19 July 1996.
This article has been cited by other articles:
![]() |
G. Ahlen, J. Soderholm, T. Tjelle, R. Kjeken, L. Frelin, U. Hoglund, P. Blomberg, M. Fons, I. Mathiesen, and M. Sallberg In Vivo Electroporation Enhances the Immunogenicity of Hepatitis C Virus Nonstructural 3/4A DNA by Increased Local DNA Uptake, Protein Expression, Inflammation, and Infiltration of CD3+ T Cells J. Immunol., October 1, 2007; 179(7): 4741 - 4753. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Lazdina, C. Hultgren, L. Frelin, M. Chen, K. Lodin, O. Weiland, G. Leroux-Roels, J. A. Quiroga, D. L. Peterson, D. R. Milich, et al. Humoral and CD4+ T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein J. Gen. Virol., June 1, 2001; 82(6): 1299 - 1308. [Abstract] [Full Text] |
||||
![]() |
J. Iroegbu, M. Birk, U. Lazdina, A. Sonnerborg, and M. Sallberg Variability and Immunogenicity of Human Immunodeficiency Virus Type 1 p24 Gene Quasispecies Clin. Vaccine Immunol., May 1, 2000; 7(3): 377 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Markine-Goriaynoff, J. T.M. van der Logt, C. Truyens, T. D. Nguyen, F. W. A. Heessen, G. Bigaignon, Y. Carlier, and J.-P. Coutelier IFN-{gamma}-independent IgG2a production in mice infected with viruses and parasites Int. Immunol., February 1, 2000; 12(2): 223 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-X. Zhang, U. Lazdina, M. Chen, D. L. Peterson, and M. Sallberg Characterization of a Monoclonal Antibody and Its Single-Chain Antibody Fragment Recognizing the Nucleoside Triphosphatase/Helicase Domain of the Hepatitis C Virus Nonstructural 3 Protein Clin. Vaccine Immunol., January 1, 2000; 7(1): 58 - 63. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |